CN102205026A - 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 - Google Patents
一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102205026A CN102205026A CN2011101390947A CN201110139094A CN102205026A CN 102205026 A CN102205026 A CN 102205026A CN 2011101390947 A CN2011101390947 A CN 2011101390947A CN 201110139094 A CN201110139094 A CN 201110139094A CN 102205026 A CN102205026 A CN 102205026A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- flos
- radix
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010009137 Chronic sinusitis Diseases 0.000 title claims abstract description 36
- 208000027157 chronic rhinosinusitis Diseases 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 50
- 239000003814 drug Substances 0.000 claims abstract description 156
- 238000011282 treatment Methods 0.000 claims abstract description 43
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 241000218378 Magnolia Species 0.000 claims abstract description 7
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 91
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- 229940079593 drug Drugs 0.000 claims description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 238000010438 heat treatment Methods 0.000 claims description 33
- 239000000243 solution Substances 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 24
- 201000009890 sinusitis Diseases 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 17
- 238000010992 reflux Methods 0.000 claims description 16
- 238000004821 distillation Methods 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 15
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 15
- 241000717739 Boswellia sacra Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 241000245240 Lonicera Species 0.000 claims description 12
- 241000545442 Radix Species 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 239000002552 dosage form Substances 0.000 claims description 11
- 239000006187 pill Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 7
- 239000007924 injection Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 235000011273 Benincasa Nutrition 0.000 claims description 6
- 241000555712 Forsythia Species 0.000 claims description 6
- 235000014435 Mentha Nutrition 0.000 claims description 6
- 241001072983 Mentha Species 0.000 claims description 6
- 241001349593 Praecitrullus Species 0.000 claims description 6
- 241000501098 Sargentodoxa Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 235000008504 concentrate Nutrition 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 4
- 230000000274 adsorptive effect Effects 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- -1 sublimed preparation Substances 0.000 claims description 4
- 239000000829 suppository Substances 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 230000002262 irrigation Effects 0.000 claims description 2
- 238000003973 irrigation Methods 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 52
- 210000004369 blood Anatomy 0.000 abstract description 51
- 230000000694 effects Effects 0.000 abstract description 51
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 10
- 239000004863 Frankincense Substances 0.000 abstract description 9
- 238000005728 strengthening Methods 0.000 abstract description 5
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract description 3
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 2
- 235000006751 Platycodon Nutrition 0.000 abstract description 2
- 244000274050 Platycodon grandiflorum Species 0.000 abstract description 2
- 229930189914 platycodon Natural products 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 2
- 244000150195 Cyperus longus Species 0.000 abstract 2
- 235000018109 Cyperus longus Nutrition 0.000 abstract 2
- 244000075634 Cyperus rotundus Species 0.000 abstract 2
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 241001251949 Xanthium sibiricum Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 238000004088 simulation Methods 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 41
- 230000036407 pain Effects 0.000 description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 33
- 201000010099 disease Diseases 0.000 description 31
- 231100000614 poison Toxicity 0.000 description 26
- 230000001717 pathogenic effect Effects 0.000 description 25
- 241000700199 Cavia porcellus Species 0.000 description 23
- 208000033809 Suppuration Diseases 0.000 description 23
- 206010019233 Headaches Diseases 0.000 description 22
- 231100000869 headache Toxicity 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 21
- 210000001331 nose Anatomy 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 20
- 210000000214 mouth Anatomy 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 18
- 230000008961 swelling Effects 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 15
- 210000004877 mucosa Anatomy 0.000 description 15
- 210000003928 nasal cavity Anatomy 0.000 description 15
- 239000003440 toxic substance Substances 0.000 description 15
- 206010028748 Nasal obstruction Diseases 0.000 description 14
- 210000003695 paranasal sinus Anatomy 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 14
- 206010007247 Carbuncle Diseases 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 13
- 239000009636 Huang Qi Substances 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 206010022000 influenza Diseases 0.000 description 11
- 210000002850 nasal mucosa Anatomy 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 10
- 239000002574 poison Substances 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 9
- 230000000202 analgesic effect Effects 0.000 description 9
- 208000026935 allergic disease Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 7
- 210000001508 eye Anatomy 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 239000013010 irrigating solution Substances 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 208000037920 primary disease Diseases 0.000 description 7
- 238000005057 refrigeration Methods 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010002653 Anosmia Diseases 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 6
- 206010018691 Granuloma Diseases 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 206010020565 Hyperaemia Diseases 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 229940023488 pill Drugs 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 206010040872 skin infection Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 206010039101 Rhinorrhoea Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 210000000959 ear middle Anatomy 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 240000006409 Acacia auriculiformis Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 235000019558 anosmia Nutrition 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000001061 forehead Anatomy 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- 229940100691 oral capsule Drugs 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 201000005404 rubella Diseases 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- APWLDLGOYJHNIK-YUELXQCFSA-N Cyperol Chemical compound C1C[C@@H](O)C(C)=C2C[C@H](C(=C)C)CC[C@]21C APWLDLGOYJHNIK-YUELXQCFSA-N 0.000 description 3
- APWLDLGOYJHNIK-CFVMTHIKSA-N Cyperol Natural products O[C@H]1C(C)=C2[C@](C)(CC1)CC[C@H](C(=C)C)C2 APWLDLGOYJHNIK-CFVMTHIKSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 241000201295 Euphrasia Species 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000009670 cang er zi wan Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229960000785 fluocinonide Drugs 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000003118 histopathologic effect Effects 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 206010039083 rhinitis Diseases 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010050515 Hyposmia Diseases 0.000 description 2
- 241001570521 Lonicera periclymenum Species 0.000 description 2
- 241000218394 Magnolia liliiflora Species 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000053227 Themus Species 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001886 ciliary effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011443 conventional therapy Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000000883 ear external Anatomy 0.000 description 2
- 210000003094 ear ossicle Anatomy 0.000 description 2
- 238000002674 endoscopic surgery Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 235000019559 hyposmia Nutrition 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000004086 maxillary sinus Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 210000004493 neutrocyte Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 229930189407 platycodin Natural products 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000037922 refractory disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 210000001944 turbinate Anatomy 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037569 Purulent discharge Diseases 0.000 description 1
- 241001113283 Respirovirus Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010070488 Upper-airway cough syndrome Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241000607757 Xenorhabdus Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110139094 CN102205026B (zh) | 2011-05-27 | 2011-05-27 | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110139094 CN102205026B (zh) | 2011-05-27 | 2011-05-27 | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102205026A true CN102205026A (zh) | 2011-10-05 |
CN102205026B CN102205026B (zh) | 2013-03-27 |
Family
ID=44694269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110139094 Active CN102205026B (zh) | 2011-05-27 | 2011-05-27 | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102205026B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614413A (zh) * | 2012-04-28 | 2012-08-01 | 曹广雪 | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 |
CN103127417A (zh) * | 2011-11-28 | 2013-06-05 | 贾宝珠 | 一种治疗鼻窦炎的药物及其制备方法 |
CN103655767A (zh) * | 2013-11-25 | 2014-03-26 | 苏建忠 | 治疗鼻窦炎的内服外用组合性中药制剂 |
CN103721061A (zh) * | 2013-12-31 | 2014-04-16 | 青岛恒波仪器有限公司 | 一种治疗慢性鼻窦炎的中药外用制剂及其制备方法 |
CN103860941A (zh) * | 2014-04-01 | 2014-06-18 | 李佃场 | 一种治疗精神***症的中药及其制备方法 |
CN104013888A (zh) * | 2014-07-01 | 2014-09-03 | 刘德学 | 治疗痰热郁肺型阻塞性肺气肿的中药组合物及其制备方法 |
CN104225200A (zh) * | 2014-09-30 | 2014-12-24 | 王林 | 一种治疗饮凌心肺型心源性哮喘的中药及制备方法 |
CN104971264A (zh) * | 2015-08-10 | 2015-10-14 | 王艳娣 | 一种治疗小儿慢性鼻窦炎的中药组合物 |
CN105055518A (zh) * | 2015-08-28 | 2015-11-18 | 柳州市妇幼保健院 | 一种治疗小儿鼻炎的中药蒸熏剂 |
CN105497122A (zh) * | 2014-09-26 | 2016-04-20 | 韦栩原 | 一种治疗口臭的药物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824195A (zh) * | 2005-12-30 | 2006-08-30 | 曹玉梅 | 治疗鼻炎鼻窦炎的药物 |
CN1943738A (zh) * | 2006-10-23 | 2007-04-11 | 杨磊 | 一种治疗慢性鼻窦炎的药物 |
CN101085095A (zh) * | 2007-06-20 | 2007-12-12 | 赵桂琴 | 一种口服治疗慢性鼻窦炎的中药组合物 |
-
2011
- 2011-05-27 CN CN 201110139094 patent/CN102205026B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824195A (zh) * | 2005-12-30 | 2006-08-30 | 曹玉梅 | 治疗鼻炎鼻窦炎的药物 |
CN1943738A (zh) * | 2006-10-23 | 2007-04-11 | 杨磊 | 一种治疗慢性鼻窦炎的药物 |
CN101085095A (zh) * | 2007-06-20 | 2007-12-12 | 赵桂琴 | 一种口服治疗慢性鼻窦炎的中药组合物 |
Non-Patent Citations (2)
Title |
---|
汪宁波等: "苍耳子散加味配合西医治疗小儿慢性鼻窦炎48例", 《陕西中医》, vol. 31, no. 7, 31 July 2010 (2010-07-31), pages 836 - 837 * |
花君霞等: "鼻窦炎的中医治疗近况", 《宁夏医学院学报》, vol. 20, no. 1, 31 March 1998 (1998-03-31), pages 90 - 91 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127417A (zh) * | 2011-11-28 | 2013-06-05 | 贾宝珠 | 一种治疗鼻窦炎的药物及其制备方法 |
CN102614413A (zh) * | 2012-04-28 | 2012-08-01 | 曹广雪 | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 |
CN102614413B (zh) * | 2012-04-28 | 2013-08-07 | 曹广雪 | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 |
CN103655767A (zh) * | 2013-11-25 | 2014-03-26 | 苏建忠 | 治疗鼻窦炎的内服外用组合性中药制剂 |
CN103655767B (zh) * | 2013-11-25 | 2016-04-20 | 苏建忠 | 治疗鼻窦炎的内服外用组合性中药制剂 |
CN103721061A (zh) * | 2013-12-31 | 2014-04-16 | 青岛恒波仪器有限公司 | 一种治疗慢性鼻窦炎的中药外用制剂及其制备方法 |
CN103860941A (zh) * | 2014-04-01 | 2014-06-18 | 李佃场 | 一种治疗精神***症的中药及其制备方法 |
CN104013888A (zh) * | 2014-07-01 | 2014-09-03 | 刘德学 | 治疗痰热郁肺型阻塞性肺气肿的中药组合物及其制备方法 |
CN105497122A (zh) * | 2014-09-26 | 2016-04-20 | 韦栩原 | 一种治疗口臭的药物 |
CN104225200A (zh) * | 2014-09-30 | 2014-12-24 | 王林 | 一种治疗饮凌心肺型心源性哮喘的中药及制备方法 |
CN104971264A (zh) * | 2015-08-10 | 2015-10-14 | 王艳娣 | 一种治疗小儿慢性鼻窦炎的中药组合物 |
CN105055518A (zh) * | 2015-08-28 | 2015-11-18 | 柳州市妇幼保健院 | 一种治疗小儿鼻炎的中药蒸熏剂 |
Also Published As
Publication number | Publication date |
---|---|
CN102205026B (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN102198236B (zh) | 一种治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN102139030B (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN101537107A (zh) | 有效治疗皮肤真菌病的外用擦剂及其制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN104740458A (zh) | 一种治疗皮肤瘙痒的中药组合物 | |
CN101518600A (zh) | 一种治疗细菌或真菌性皮肤病的中药组合物及其制备方法 | |
CN102000194B (zh) | 一种治疗中耳炎的中药组合物及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN102614413B (zh) | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 | |
CN103720841B (zh) | 一种治疗慢性化脓性中耳炎的中药制剂及其制备方法 | |
CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
CN101601782A (zh) | 一种治疗脚癣的复方酊剂 | |
CN103041247A (zh) | 一种治疗***炎的中药栓剂及其制备方法 | |
CN103721138A (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN104971271A (zh) | 一种治疗瘀湿化热型***增生的药物及制备方法 | |
CN104667183A (zh) | 治疗湿热邪滞型化脓性骨髓炎的药物制剂及其制备方法 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN104127737A (zh) | 用于防治痔疮术后并发症的药物组合物及其制备方法 | |
CN104997949A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN105396007A (zh) | 一种防治霉菌性***炎的妇科外用洗液 | |
CN105998542A (zh) | 一种治疗急性咽喉炎的中药喷剂及其制备方法 | |
CN105395765A (zh) | 一种用于治疗慢性鼻窦炎的外敷中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Lu Yan Inventor after: Li Dianchang Inventor after: Wei Zhigang Inventor before: Liang Diecong Inventor before: Li Dianchang Inventor before: Wei Zhigang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIANG YICONG LI DIANCHANG WEI ZHIGANG TO: LU YAN LI DIANCHANG WEI ZHIGANG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG WEEK TOURISM DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: LI DIANCHANG Effective date: 20130716 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266061 QINGDAO, SHANDONG PROVINCE TO: 226121 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130716 Address after: 226121 Jiangsu province Nantong markets three factory town Road No. 79 Patentee after: Nantong seven Tourism Development Co., Ltd. Address before: 266061 phase 12-2-402, Li Hai garden, Laoshan District, Shandong, Qingdao Patentee before: Li Dianchang |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190410 Address after: 710068 Room 30705, Block B, Jinqiao International Plaza, 50 Science and Technology Road, Xi'an High-tech Zone, Shaanxi Province Patentee after: XI'AN BOAI PHARMACEUTICAL CO, LTD. Address before: 226121 No. three vegetable market road, three factory town, Nantong, Jiangsu Patentee before: Nantong seven Tourism Development Co., Ltd. |
|
TR01 | Transfer of patent right |